Helen Tayton Martin - Chief Business & Strgy Officer at Adaptimmune Therapeutics PLC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business & Strgy Officer
Stock Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Helen Tayton Martin since 11/4/2023

Holdings reported by Helen Tayton Martin for Adaptimmune Therapeutics PLC

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Option to purchase Ordinary Shares 565K Jan 15, 2024 Direct Ordinary Shares

Transactions reported by Helen Tayton Martin for Adaptimmune Therapeutics PLC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.